A Trial Comparing Adductor Canal Catheter and Intraarticular Catheter Following Primary Total Knee Arthroplasty
Acute Pain, Regional Anesthesia Morbidity
About this trial
This is an interventional treatment trial for Acute Pain focused on measuring Adductor Canal Catheter, Intraarticular Catheter, Arthroplasty, Replacement, Knee
Eligibility Criteria
Inclusion Criteria:
- Age 40-85
- American Society of Anesthesiologists (ASA) Physical Status (PS) 1-3.
- Undergoing Unilateral, Primary, Total Knee Arthroplasty
- English as native language
Exclusion Criteria:
- Patient refusal
- History of opioid dependence
- Contraindication to peripheral nerve block
- Pre-existing significant neuropathy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Adductor Canal Catheter
Intraarticular Catheter
Postoperatively, patients will be brought to the PACU. The needle insertion site, approximately 10cm proximal to their operative knee, will be exposed. A sterile field will be utilized and the femoral artery is identified with a high frequency linear transducer proximal to the operative knee. 18g insulated Tuohy needle will be inserted in an out-of-plane approach through the sartorius muscle to a final location in close proximity to the saphenous nerve. Once satisfied with needle placement and following negative aspiration, 15 cc's of 0.5% ropivicaine will be injected through the needle under visualization. A 20-g multi-orifice catheter will be inserted approximately 4 cm beyond the needle tip and secured.
Intra-articular catheters will be placed by the surgeon at the end of the procedure, before wound closure. A bupivacaine 0.5% infusion will be admin through the On-Q system and continued for 48 hours postoperatively.